RACGAP1 and liver cancer: Furthermore, the output of the KM plot analysis confirmed this positive correlation in all models studied of breast, lung, gastric, and liver cancers, which recommends the use of RACGAP1 as a prognostic biomarker in the above-mentioned tumors.